Keith Sultan

1.7k total citations
52 papers, 527 citations indexed

About

Keith Sultan is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, Keith Sultan has authored 52 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 20 papers in Epidemiology and 20 papers in Genetics. Recurrent topics in Keith Sultan's work include Inflammatory Bowel Disease (20 papers), Microscopic Colitis (19 papers) and Eosinophilic Esophagitis (6 papers). Keith Sultan is often cited by papers focused on Inflammatory Bowel Disease (20 papers), Microscopic Colitis (19 papers) and Eosinophilic Esophagitis (6 papers). Keith Sultan collaborates with scholars based in United States, Malaysia and Israel. Keith Sultan's co-authors include Iuliana Shapira, Emanuela Taioli, Annette Lee, Burton I. Korelitz, Sundas Khan, Arun Swaminath, Arvind J. Trindade, Georgia Panagopoulos, Sumant Inamdar and Michaela Oswald and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Cancer Research.

In The Last Decade

Keith Sultan

49 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Sultan United States 12 170 168 155 117 107 52 527
Rosa Coelho Portugal 13 82 0.5× 207 1.2× 186 1.2× 179 1.5× 29 0.3× 62 504
Christine N. Manser Switzerland 15 89 0.5× 204 1.2× 267 1.7× 250 2.1× 50 0.5× 26 779
Jinzhong Li China 11 117 0.7× 117 0.7× 72 0.5× 89 0.8× 38 0.4× 36 472
Jacob Broder Brodersen Denmark 10 85 0.5× 111 0.7× 223 1.4× 133 1.1× 30 0.3× 25 481
Mariann Rutka Hungary 11 47 0.3× 125 0.7× 195 1.3× 145 1.2× 25 0.2× 51 398
J Green United Kingdom 7 65 0.4× 135 0.8× 79 0.5× 291 2.5× 60 0.6× 7 539
Isadora Rosa Portugal 13 59 0.3× 173 1.0× 269 1.7× 223 1.9× 28 0.3× 48 588
Mathieu Uzzan France 14 61 0.4× 145 0.9× 217 1.4× 151 1.3× 18 0.2× 33 552
S Vavricka Switzerland 12 119 0.7× 275 1.6× 236 1.5× 153 1.3× 11 0.1× 27 649
Eun Hye Oh South Korea 12 49 0.3× 163 1.0× 226 1.5× 222 1.9× 14 0.1× 54 466

Countries citing papers authored by Keith Sultan

Since Specialization
Citations

This map shows the geographic impact of Keith Sultan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Sultan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Sultan more than expected).

Fields of papers citing papers by Keith Sultan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Sultan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Sultan. The network helps show where Keith Sultan may publish in the future.

Co-authorship network of co-authors of Keith Sultan

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Sultan. A scholar is included among the top collaborators of Keith Sultan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Sultan. Keith Sultan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nirenberg, Sharon, Jean–Frédéric Colombel, Adam S. Faye, et al.. (2024). Intravenous Steroids Do Not Improve Short-Term Outcomes of Patients With Crohn’s Disease Presenting With an Acute Small Bowel Obstruction. Crohn s & Colitis 360. 7(1). otae064–otae064.
3.
Lowell, Jeffrey A., et al.. (2024). Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis. Digestive Diseases and Sciences. 69(10). 3920–3931. 1 indexed citations
4.
Swaminath, Arun, et al.. (2023). Cannabis Use and Its Association With Thirty- and Ninety-Day Hospital Readmissions for Patients Admitted for an Inflammatory Bowel Disease Exacerbation. Journal of Clinical Medicine Research. 15(2). 99–108. 4 indexed citations
5.
Swaminath, Arun, et al.. (2022). Patient With Ulcerative Colitis and Failure of Ustekinumab Responds to Risankizumab: Similar Is Not Identical. Inflammatory Bowel Diseases. 28(10). e140–e141. 2 indexed citations
6.
Swaminath, Arun, et al.. (2022). A Literature Review of Ozanimod Therapy in Inflammatory Bowel Disease: From Concept to Practical Application. Therapeutics and Clinical Risk Management. Volume 18. 913–927. 9 indexed citations
7.
Sultan, Keith, et al.. (2021). Acute kidney injury in patients hospitalized with COVID-19 in a Tertiary Care Hospital of Islamabad. 32(8). 81–85. 1 indexed citations
8.
Kohn, Nina, et al.. (2021). Clostridiodes difficile Treatment Guided by Polymerase Chain Reaction Stool Testing Does not Alter Outcomes for Patients With Inflammatory Bowel Disease. Journal of Clinical Medicine Research. 13(12). 572–574. 1 indexed citations
9.
Kayal, Maia, Ryan C. Ungaro, Kanika Kamal, et al.. (2021). Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability. Clinical Gastroenterology and Hepatology. 20(4). e761–e769. 11 indexed citations
10.
Sultan, Keith, et al.. (2021). Corticosteroid and Biologic Use Not Associated With Adverse Outcomes for Inflammatory Bowel Disease Patients Hospitalized With COVID-19. Gastroenterology Research. 14(6). 324–333. 1 indexed citations
11.
Liu, Yan, et al.. (2021). Gastrointestinal Sequelae 3 and 6 Months After Hospitalization for Coronavirus Disease 2019. Clinical Gastroenterology and Hepatology. 19(11). 2438–2440.e1. 17 indexed citations
12.
Sultan, Keith, et al.. (2020). Review of inflammatory bowel disease and COVID-19. World Journal of Gastroenterology. 26(37). 5534–5542. 23 indexed citations
13.
14.
Agrawal, Manasi, Shirley Cohen‐Mekelburg, Maia Kayal, et al.. (2019). Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio‐economic factors. Alimentary Pharmacology & Therapeutics. 49(5). 564–571. 22 indexed citations
15.
Sultan, Keith, et al.. (2019). Increased Transfusion Requirements with Pharmacologic Thromboembolism Prophylaxis During Inflammatory Bowel Disease Exacerbation. Digestive Diseases and Sciences. 64(11). 3256–3262. 5 indexed citations
16.
Khan, Sundas, et al.. (2018). Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting. World Journal of Gastrointestinal Pharmacology and Therapeutics. 9(1). 8–13. 1 indexed citations
17.
Zylberberg, Haley M., et al.. (2018). Hereditary diffuse gastric cancer: One family’s story. World Journal of Clinical Cases. 6(1). 1–5. 8 indexed citations
18.
Inamdar, Sumant, Matthew McKinley, Ronald Greenberg, et al.. (2018). Incremental yield of dysplasia detection in Barrett’s esophagus using volumetric laser endomicroscopy with and without laser marking compared with a standardized random biopsy protocol. Gastrointestinal Endoscopy. 88(1). 35–42. 34 indexed citations
19.
Shapira, Iuliana, Keith Sultan, Bhoomi Mehrotra, & Daniel R. Budman. (2010). Emerging role of small ribonucleic acids in gastrointestinal tumors. Critical Reviews in Oncology/Hematology. 76(3). 173–185. 1 indexed citations
20.
Korelitz, Burton I., et al.. (2007). A Prospective Open-label Trial of Remicade® in Patients With Severe Exacerbation of Crohn's Disease Requiring Hospitalization. Journal of Clinical Gastroenterology. 41(7). 677–681. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa Coelho Breakdown of academic impact, for papers by Christine N. Manser Breakdown of academic impact, for papers by Jinzhong Li Breakdown of academic impact, for papers by Jacob Broder Brodersen Breakdown of academic impact, for papers by Mariann Rutka Breakdown of academic impact, for papers by J Green Breakdown of academic impact, for papers by Isadora Rosa Breakdown of academic impact, for papers by Mathieu Uzzan Breakdown of academic impact, for papers by S Vavricka Breakdown of academic impact, for papers by Eun Hye Oh
Rankless by CCL
2026